Soleno Therapeutics Inc (SLNO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -30,774 | -13,335 | -15,385 | -12,065 | -15,909 |
| Depreciation Amortization | 1,958 | 1,963 | 1,611 | 19 | 108 |
| Income taxes - deferred | N/A | N/A | -1,651 | N/A | N/A |
| Accounts receivable | N/A | N/A | N/A | N/A | -156 |
| Accounts payable and accrued liabilities | 1,061 | 249 | 191 | -77 | 212 |
| Other Working Capital | 2,499 | 82 | -24 | 361 | 810 |
| Other Operating Activity | 7,881 | -642 | 5,308 | -1,736 | 4,635 |
| Operating Cash Flow | $-17,375 | $-11,683 | $-9,950 | $-13,498 | $-10,299 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 500 | 0 | N/A | N/A | N/A |
| PPE Investments | -21 | -8 | -2 | -15 | -56 |
| Net Acquisitions | N/A | N/A | -573 | N/A | -1,250 |
| Other Investing Activity | 49 | -172 | 729 | -24 | -15 |
| Investing Cash Flow | $528 | $-180 | $154 | $-39 | $-1,321 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 14,483 | 16,302 | 25,008 | 70 | 5,605 |
| Other Financing Activity | -2 | 1,525 | -838 | 10,698 | 3,553 |
| Financing Cash Flow | $14,481 | $17,827 | $24,170 | $10,768 | $9,158 |
| Beginning Cash Position | 23,099 | 17,135 | 2,761 | 5,495 | 7,957 |
| End Cash Position | 20,733 | 23,099 | 17,135 | 2,726 | 5,495 |
| Net Cash Flow | $-2,366 | $5,964 | $14,374 | $-2,769 | $-2,462 |
| Free Cash Flow | |||||
| Operating Cash Flow | -17,375 | -11,683 | -9,950 | -13,498 | -10,299 |
| Capital Expenditure | -21 | -8 | -2 | -15 | -56 |
| Free Cash Flow | -17,396 | -11,691 | -9,952 | -13,513 | -10,355 |